Net Loss Per Share Attributable to Guardant Health, Inc. Common Stockholders

12 Months Ended

Dec. 31, 2023

Net Loss Per Share Attributable to Guardant Health, Inc. Common Stockholders

The following table sets forth the computation of the basic and diluted net loss per share attributable to Guardant Health, Inc. common stockholders:


	Year Ended December 31,
	2023		2022		2021

	(in thousands, except per share data)
Net loss	$	(479,449)	$	(654,588)	$	(384,770)
Adjustment of redeemable noncontrolling interest	—		—		(20,900)
Net loss attributable to Guardant Health, Inc. common stockholders, basic and diluted	$	(479,449)	$	(654,588)	$	(405,670)
Net loss per share attributable to Guardant Health, Inc. common stockholders, basic and diluted	$	(4.28)	$	(6.41)	$	(4.00)
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, basic and diluted	111,988		102,178		101,314

Since the Company was in a loss position for all periods presented, basic net loss per share attributable to Guardant Health, Inc. common stockholders is the same as diluted net loss per share attributable to Guardant Health, Inc. common stockholders, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to Guardant Health, Inc. common stockholders for the periods presented as they had an anti-dilutive effect:


	Year Ended December 31,
	2023	2022	2021

	(in thousands)



Stock options issued and outstanding	3,566	2,799	2,715
Restricted stock units	3,474	2,342	1,208
MSUs	2,261	2,261	2,357
PSUs	389	354	397
ESPP obligation	176	105	45
Common stock subject to repurchase	—	—	7
Convertible senior notes	8,225	8,225	8,225
Total	18,091	16,086	14,954